Explore Our Network

Explore MTEC's network of innovators, investors, and research organizations—along with patents and funding opportunities—advancing medical technologies for military and civilian health.

Showing 3 Patents
Method of reducing mesothelin-expressing tumor burden by administration of T cells comprising mesothelin-targeted chimeric antigen receptors

18-07-2023 • US-11702472-B2

ADUSUMILLI, PRASAD S. • SADELAIN, MICHEL • DIMITROV, DIMITER S. • FENG, YANG

Memorial Sloan Kettering Cancer Center • US Department of Health and Human Services

Mesothelin-targeted chimeric antigen receptors and uses thereof

28-04-2020 • US-10633441-B2

ADUSUMILLI, PRASAD S. • SADELAIN, MICHEL • DIMITROV, DIMITER S. • FENG, YANG

Memorial Sloan Kettering Cancer Center • US Department of Health and Human Services

Mesothelin-targeted chimeric antigen receptors and methods of making them

21-01-2020 • US-10538588-B2

ADUSUMILLI, PRASAD S. • SADELAIN, MICHEL • DIMITROV, DIMITER S. • FENG, YANG

Memorial Sloan Kettering Cancer Center • US Department of Health and Human Services

Owner
Inventors
Assignee
Patent Type
Publication Year

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.